FDA Flags Up Repeat Issues At Pfizer's McPherson Plant in Kansas

Problems persist at Pfizer’s US manufacturing facility in McPherson, Kansas, after an FDA audit led the agency to issue a ‘Form 483’ report with eight observations, seven of which were repeated from inspections dating back to as far as 2012.  

Calendar
Pfizer site repeats errors cited as far back as 2012 • Source: Shutterstock

Pfizer has been issued a ‘Form 483’ report by the US Food and Drug Administration (FDA) citing eight observations – of which seven are repeat deficiencies – following an inspection from 23 July to 8 August at its former Hospira US manufacturing site in McPherson, Kansas.

According to the 10-page report, Pfizer did not adequately investigate mold contamination results, leading to an undisclosed number of batches...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Manufacturing

More from Business